The Inside Scoop

The US Securities and Exchange Commission recently launched a formal investigation into possible insider trading at the Cambridge, Mass.-based biotechnology firm Biogen Idec.

| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

The US Securities and Exchange Commission recently launched a formal investigation into possible insider trading at the Cambridge, Mass.-based biotechnology firm Biogen Idec. In March, Thomas Bucknum, the company's chief counsel, resigned following reports that he had sold stock in the firm just as potential safety problems with the multiple sclerosis drug Tysabri were coming to light. When those safety problems were made public in February, the drug was withdrawn from the market and Biogen's stock plummeted more than 40% in a single day.

Other company officials reportedly sold stock before the public announcement, and charges could be forthcoming. The scandal has been disturbing to the biotechnology and pharmaceutical industries, in part because it echoes the debacle that rocked ImClone Systems not long ago. Sam Waksal, ImClone's former CEO, is currently serving an 87-month prison sentence after pleading guilty in 2002 to securities fraud, bank fraud, and other charges related ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Kate Fodor

    This person does not yet have a bio.

Published In

Share
Image of a woman in a microbiology lab whose hair is caught on fire from a Bunsen burner.
April 1, 2025, Issue 1

Bunsen Burners and Bad Hair Days

Lab safety rules dictate that one must tie back long hair. Rosemarie Hansen learned the hard way when an open flame turned her locks into a lesson.

View this Issue
Faster Fluid Measurements for Formulation Development

Meet Honeybun and Breeze Through Viscometry in Formulation Development

Unchained Labs
Conceptual image of biochemical laboratory sample preparation showing glassware and chemical formulas in the foreground and a scientist holding a pipette in the background.

Taking the Guesswork Out of Quality Control Standards

sartorius logo
An illustration of PFAS bubbles in front of a blue sky with clouds.

PFAS: The Forever Chemicals

sartorius logo
Unlocking the Unattainable in Gene Construction

Unlocking the Unattainable in Gene Construction

dna-script-primarylogo-digital

Products

Atelerix

Atelerix signs exclusive agreement with MineBio to establish distribution channel for non-cryogenic cell preservation solutions in China

Green Cooling

Thermo Scientific™ Centrifuges with GreenCool Technology

Thermo Fisher Logo
Singleron Avatar

Singleron Biotechnologies and Hamilton Bonaduz AG Announce the Launch of Tensor to Advance Single Cell Sequencing Automation

Zymo Research Logo

Zymo Research Launches Research Grant to Empower Mapping the RNome